Klinikum im Friedrichshain

Running trials

• Recruiting

  Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

  NCT07176312· Phase 2· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· Phase 3· Source

• Recruiting

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· Phase 3· Source

• Recruiting

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· Phase 3· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Source

• Active, not recruiting

  A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

  NCT05993234· Source

• Active, not recruiting

  A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

  NCT05685238· Phase 3· Source

• Enrolling by invitation

  Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

  NCT04451044· Source

• Enrolling by invitation

  A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

  NCT04574076· Source

• Active, not recruiting

  A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

  NCT04158934· Source

• Enrolling by invitation

  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  NCT03745924· Source

• Active, not recruiting

  Reducing Lung CongestIon Symptoms in Advanced Heart Failure

  NCT03499236· Source

• Active, not recruiting

  The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

  NCT03171311· Source

• Recruiting

  The European Paediatric Network for Haemophilia Management ( PedNet Registry)

  NCT02979119· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and esophageal cancer3 recruiting
• Haemophilia3 recruiting
• Lung cancer2 recruiting
• Coronary artery disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· Phase 3· Source

• Completed

  A Study of BAX 888 in Male Adults With Severe Hemophilia A

  NCT03370172· Phase 1/2· Source

Trial sites

• Department of Internal Medicine, Hemophilia Treatment Center, Vivantes Klinikum im Friedrichshain1 trial
• Vivantes Klinikum im Friedrichshain9 trials
• Vivantes - Klinikum Im Friedrichshain;Innere Medizin ? Hämatologie, Onkologie und Palliativmedizin1 trial
• Vivantes Klinikum im Friedrichshain - Landsberger Allee1 trial
• Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain4 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Haemophilia15 works · 7 trials